Dr Reddy’s Laboratories launched its injectable semaglutide under the brand name Obeda for the management of type 2 diabetes in the Indian market. Dr Reddy’s is the first Indian company to receive ...
Appointment of Rimidi founder Dr. Lucienne Ide as CMO strengthens HRS’s clinical leadership and advances their vision for enterprise remote patient care. My focus will be on ensuring our technology ...